Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
OptimizeRx Corporation - Common Stock
(NQ:
OPRX
)
8.310
-0.250 (-2.92%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about OptimizeRx Corporation - Common Stock
< Previous
1
2
3
4
5
Next >
Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance
May 02, 2023
Physicians report that they are encountering brand information across multiple digital and in-person channels, yet still lack key information on patient eligibility, affordability, and access
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET
April 26, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report
April 04, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
A Preview Of OptimizeRx's Earnings
March 07, 2023
Via
Benzinga
Analyst Ratings for OptimizeRx
November 01, 2022
Within the last quarter, OptimizeRx (NASDAQ:OPRX) has observed the following analyst ratings:
Via
Benzinga
Financial Times Ranks OptimizeRx Amongst The Americas’ Fastest Growing Companies for the Fourth Consecutive Year
March 29, 2023
– AI driven RWD deals grow from 6 completed in 2022 to several dozen in pipeline today, representing the rapid adoption of OptimizeRx’s health technology enablement platform services
From
OptimizeRx Corporation
Via
GlobeNewswire
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
March 14, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
OptimizeRx Authorizes $15 Million Share Repurchase Program
March 14, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
March 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 09, 2023
Via
Benzinga
OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients
March 09, 2023
Deal will enable high-growth patient services company to streamline and enhance its services with OptimizeRx’s technology solutions
From
OptimizeRx Corporation
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 08, 2023
Via
Benzinga
OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results
March 08, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
Earnings Scheduled For March 8, 2023
March 08, 2023
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
Via
Benzinga
OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET
February 23, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
February 09, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference
January 04, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
November 28, 2022
From
OptimizeRx Corporation
Via
GlobeNewswire
Nasdaq Drops 200 Points; Meta Platforms Shares Jump
November 09, 2022
U.S. stocks traded lower toward the end of trading , with the Nasdaq Composite dropping 200 points on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 09, 2022
Gainers
Via
Benzinga
Crude Oil Down Over 2%; Outset Medical Shares Spike Higher
November 09, 2022
U.S. stocks traded lower midway through trading as investors focused on the outcome of the midterm elections.
Via
Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
November 10, 2022
Gainers
Via
Benzinga
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
November 09, 2022
Gainers
Via
Benzinga
Meta Platforms, Hilton Grand Vacations, D.R. Horton, And Some Other Big Stocks Moving Higher On Wednesday
November 09, 2022
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
OptimizeRx Reports Third Quarter 2022 Financial Results
November 08, 2022
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired Event
October 20, 2022
Virtual event takes place December 1, 2022
From
OptimizeRx Corporation
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Upgrades
Via
Benzinga
OptimizeRx Sets Third Quarter Fiscal 2022 Conference Call for Tuesday, November 8 at 4:30 p.m. ET
October 19, 2022
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Announces Strong Results from its use of Previously Announced AI/RWE Solution
October 11, 2022
Analysis demonstrates effectiveness of OptimizeRx’s real-world evidence solution to identify patients suitable for a specialty therapy within a narrow timeframe
From
OptimizeRx Corporation
Via
GlobeNewswire
How Is The Market Feeling About OptimizeRx?
August 15, 2022
OptimizeRx's (NASDAQ:OPRX) short percent of float has fallen 12.86% since its last report. The company recently reported that it has 1.22 million shares sold short,...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.